FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells.

Title:: FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells.
Document type:: Letter; Letter
Author(s):: Sperk, Anna; Gabriel, Antje; Koch, Daniela; Augsburger, Abirami; Sanchez, Victoria; Brockelt, David; Öllinger, Rupert; Engleitner, Thomas; Giansanti, Piero; Ludwig, Romina; Auf der Maur, Priska; Walter, Wencke; Haferlach, Torsten; Jeremias, Irmela; Rad, Roland; Steigenberger, Barbara; Kuster, Bernhard; Eichner, Ruth; Bassermann, Florian
Journal title abbreviation:: Leukemia
Year:: 2024
Journal volume:: 38
Journal issue:: 9
Pages contribution:: 2027-2031
Fulltext / DOI:: doi:10.1038/s41375-024-02345-0
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/39014197
Print-ISSN:: 0887-6924
TUM Institution:: 611; Klinik und Poliklinik für Innere Medizin III, Hämatologie und Onkologie (Prof. Bassermann); Professur für Molekulare Onkologie und Funktionelle Genomik (Prof. Rad)
BibTeX